Laba Combinations
Laba Combinations is a therapeutic framework in respiratory medicine that integrates a long-acting beta2-adrenergic agonist with an inhaled corticosteroid or other controller agent within a single inhaler device to enhance treatment efficacy in obstructive lung diseases.
73
Publications
4K
Citations
437
Authors
245
Institutions
Publications per year
2017–2026
35
Parents
73
1–5 of 73
437
5
h-index
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 437
245

University of Colorado Denver
Denver, United States
8 h-index
16 publications
4.5K citations

National Jewish Health
Denver, United States
8 h-index
15 publications
4.5K citations

Brigham and Women's Hospital
Boston, United States
6 h-index
17 publications
2K citations

Research Triangle Park Foundation
Durham, United States
6 h-index
14 publications
453 citations
Harvard University
Cambridge, United States
5 h-index
11 publications
1.7K citations
University of Wisconsin–Madison
Madison, United States
5 h-index
6 publications
1.1K citations

University of Rome Tor Vergata
Rome, Italy
5 h-index
14 publications
673 citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
5 h-index
18 publications
727 citations
1–8 of 245
NEJM · 7 publications · 1.5K citations
7
h-index
6 publications · 124 citations
6
h-index
5 publications · 161 citations
5
h-index
3 publications · 132 citations
3
h-index
Repository · 2 publications · 55 citations
2
h-index
1–5